Innovation in the pharmaceutical industry has never been more exciting than it is right now, and there are some excellent companies that could be big winners for patient investors. In this Fool Live clip, recorded on Sept. 15, Fool.com contributor Jason Hall explains to Senior Analyst Asit Sharma why Compass Pathways (NASDAQ: CMPS) in particular is on his watch list now. Jason Hall: This is something that I'm going to talk about.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting